Immatics N.V. (IMTX) vs LB Pharmaceuticals Inc (LBRX)
Immatics N.V. and LB Pharmaceuticals Inc are both Biotechnology companies. Immatics N.V. and LB Pharmaceuticals Inc are of similar size ($1.3B and $1.2B). LB Pharmaceuticals Inc has the higher net margin (0.00% vs −489.4%) and the lower return on invested capital (−1,304.8% vs −84.8%). Across the 12 metrics below, LB Pharmaceuticals Inc leads on 7 and Immatics N.V. on 5.
Valuation
Profitability
| Metric | IMTX | LBRX | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | — | 65.16% |
| Operating margin | (536.26%) | 0.00% | 0.00% |
| Net margin | (489.35%) | 0.00% | 0.00% |
| Free cash flow margin | (488.01%) | 0.00% | 0.00% |
| Return on equity | (48.53%) | (72.07%) | (57.72%) |
| Return on assets | (39.83%) | (47.38%) | (49.22%) |
| Return on invested capital | (84.83%) | (1,304.79%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack